Cumberland Pharmaceuticals CPIX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's software and technology licenses, net?
- Cumberland Pharmaceuticals (CPIX) reported software and technology licenses, net of $2.93M in Q1 2026.
- How has Cumberland Pharmaceuticals's software and technology licenses, net changed year-over-year?
- Cumberland Pharmaceuticals's software and technology licenses, net increased by 6.7% year-over-year, from $2.74M to $2.93M.
- What is the long-term trend for Cumberland Pharmaceuticals's software and technology licenses, net?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's software and technology licenses, net has grown at a -1.7% compound annual growth rate (CAGR), from $3.23M to $2.97M.